{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Non-treatment&page=66", "query": { "intervention": "Non-treatment", "page": 66 }, "page_size": 10 }, "pagination": { "page": 66, "page_size": 10, "total_count": 20873, "total_pages": 2088, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Non-treatment&page=67&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Non-treatment&page=65&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-20T12:45:45.982Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03828019", "title": "Adalimumab vs. Conventional Immunosuppression for Uveitis Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Uveitis" ], "interventions": [ { "name": "Adalimumab (ADA)", "type": "BIOLOGICAL" }, { "name": "Conventional immunosuppression (CON)", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "JHSPH Center for Clinical Trials", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": null, "sex": "ALL", "summary": "13 Years and older" }, "enrollment_count": 227, "start_date": "2019-09-16", "completion_date": "2024-09-09", "has_results": true, "last_update_posted_date": "2025-05-16", "last_synced_at": "2026-10-20T12:45:45.982Z", "location_count": 19, "location_summary": "Los Angeles, California • San Francisco, California • Miami, Florida + 14 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT03828019" }, { "nct_id": "NCT06801067", "title": "A Study of SER-155 to Treat Diarrhea in People on Immunotherapy", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Diarrhea", "Enterocolitis" ], "interventions": [ { "name": "SER-155", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 15, "start_date": "2025-01-24", "completion_date": "2027-01-24", "has_results": false, "last_update_posted_date": "2026-07-28", "last_synced_at": "2026-10-20T12:45:45.982Z", "location_count": 7, "location_summary": "Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more", "locations": [ { "city": "Basking Ridge", "state": "New Jersey" }, { "city": "Middletown", "state": "New Jersey" }, { "city": "Montvale", "state": "New Jersey" }, { "city": "Commack", "state": "New York" }, { "city": "Harrison", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT06801067" }, { "nct_id": "NCT06501781", "title": "Peer Behavioral Activation Utilization to Improve Substance Use and HIV Outcomes in People Receiving Long Acting Injectable-PrEP/ART (PUSH)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "HIV Infections", "Substance Use" ], "interventions": [ { "name": "Peer Activate-LAI", "type": "BEHAVIORAL" }, { "name": "Standard of Care HIV treatment or prevention with LAI-PrEP/ART", "type": "OTHER" } ], "intervention_types": [ "BEHAVIORAL", "OTHER" ], "sponsor": "University of Maryland, Baltimore", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "88 Years", "sex": "ALL", "summary": "18 Years to 88 Years" }, "enrollment_count": 186, "start_date": "2025-03-18", "completion_date": "2028-12", "has_results": false, "last_update_posted_date": "2025-10-31", "last_synced_at": "2026-10-20T12:45:45.982Z", "location_count": 2, "location_summary": "Washington D.C., District of Columbia • Baltimore, Maryland", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT06501781" }, { "nct_id": "NCT05762419", "title": "FUS Etoposide for DMG", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Diffuse Intrinsic Pontine Glioma", "Diffuse Midline Glioma, H3 K27M-Mutant" ], "interventions": [ { "name": "Etoposide; Oral, 50 Mg", "type": "DRUG" }, { "name": "Focused ultrasound with neuro-navigator-controlled sonication", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Columbia University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "21 Years", "sex": "ALL", "summary": "4 Years to 21 Years" }, "enrollment_count": 10, "start_date": "2023-06-05", "completion_date": "2027-12", "has_results": false, "last_update_posted_date": "2026-01-28", "last_synced_at": "2026-10-20T12:45:45.982Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05762419" }, { "nct_id": "NCT00004230", "title": "Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cancer" ], "interventions": [ { "name": "captopril", "type": "DRUG" }, { "name": "cyclophosphamide", "type": "DRUG" }, { "name": "autologous bone marrow transplantation", "type": "PROCEDURE" }, { "name": "peripheral blood stem cell transplantation", "type": "PROCEDURE" }, { "name": "radiation therapy", "type": "RADIATION" } ], "intervention_types": [ "DRUG", "PROCEDURE", "RADIATION" ], "sponsor": "Northwestern University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 35, "start_date": "1999-10", "completion_date": "2002-03", "has_results": false, "last_update_posted_date": "2012-06-06", "last_synced_at": "2026-10-20T12:45:45.982Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00004230" }, { "nct_id": "NCT01053819", "title": "Can We Miss Pigmented Lesions in Psoriasis Patients?", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Psoriasis", "Melanoma", "Non-melanoma Skin Cancer" ], "interventions": [ { "name": "etanercept", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Alabama at Birmingham", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "19 Years", "maximum_age": null, "sex": "ALL", "summary": "19 Years and older" }, "enrollment_count": 6, "start_date": "2007-09", "completion_date": "2012-04", "has_results": true, "last_update_posted_date": "2018-02-23", "last_synced_at": "2026-10-20T12:45:45.982Z", "location_count": 1, "location_summary": "Birmingham, Alabama", "locations": [ { "city": "Birmingham", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT01053819" }, { "nct_id": "NCT04240093", "title": "CoMBAT Opioid Use Disorder: A Combined Medication and Behavioral Activation Treatment for People Living With Opioid Use Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Opioid-use Disorder", "Medication Adherence", "Health Care Utilization" ], "interventions": [ { "name": "Behavioral Activation (BA) Therapy", "type": "BEHAVIORAL" }, { "name": "Substance Abuse and Health Navigation Counseling", "type": "BEHAVIORAL" }, { "name": "Medications for Opioid Use Disorder", "type": "OTHER" } ], "intervention_types": [ "BEHAVIORAL", "OTHER" ], "sponsor": "Brown University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 44, "start_date": "2019-11-15", "completion_date": "2022-03-31", "has_results": true, "last_update_posted_date": "2023-05-26", "last_synced_at": "2026-10-20T12:45:45.982Z", "location_count": 1, "location_summary": "Providence, Rhode Island", "locations": [ { "city": "Providence", "state": "Rhode Island" } ], "official_url": "https://clinicaltrials.gov/study/NCT04240093" }, { "nct_id": "NCT01891721", "title": "Evaluating Two Types of Cognitive Training in Veterans With Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "Brain Fitness Program (BFP)", "type": "BEHAVIORAL" }, { "name": "Cognitive Package (Cogpack)", "type": "BEHAVIORAL" }, { "name": "Commercial Computer Games (Sporcle)", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "VA Office of Research and Development", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "25 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "25 Years to 65 Years" }, "enrollment_count": 105, "start_date": "2013-11-21", "completion_date": "2018-06-30", "has_results": true, "last_update_posted_date": "2019-08-14", "last_synced_at": "2026-10-20T12:45:45.982Z", "location_count": 2, "location_summary": "Los Angeles, California • West Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "West Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01891721" }, { "nct_id": "NCT06344416", "title": "Open Label, Controlled, Post Marketing, Registry Study of Ribociclib (Ribo) Treatment Adherence and Patient Reported Outcomes in Participants Using ReX Technology Platform", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Any Solid Oral Medication" ], "interventions": [ { "name": "Use of ReX to dispense and monitor solid oral medication therapy.", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Dosentrx Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 200, "start_date": "2024-03-30", "completion_date": "2026-01-30", "has_results": false, "last_update_posted_date": "2025-03-12", "last_synced_at": "2026-10-20T12:45:45.982Z", "location_count": 4, "location_summary": "Minneapolis, Minnesota • Austin, Texas • Richmond, Virginia + 1 more", "locations": [ { "city": "Minneapolis", "state": "Minnesota" }, { "city": "Austin", "state": "Texas" }, { "city": "Richmond", "state": "Virginia" }, { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT06344416" }, { "nct_id": "NCT04796584", "title": "Efficacy of COVID-19 Vaccination in Patients With Multiple Sclerosis Treated With Immune Modulating Medication", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Multiple Sclerosis" ], "interventions": [ { "name": "Analysis of cell-mediated and antibody-mediated immunity to SARS-CoV-2 virus", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Providence Health & Services", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 20, "start_date": "2022-07-11", "completion_date": "2022-10-25", "has_results": false, "last_update_posted_date": "2023-04-03", "last_synced_at": "2026-10-20T12:45:45.982Z", "location_count": 1, "location_summary": "Portland, Oregon", "locations": [ { "city": "Portland", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT04796584" } ] }